24
Participants
Start Date
December 31, 2018
Primary Completion Date
December 31, 2025
Study Completion Date
December 31, 2025
CPI-613
CPI-613 \[2,500 mg/m2/day IV\] over 2 hours (+/- 10 mins) Induction tx: Cycle 1 and 2: Treatment on Days 1-5 (Each cycle is 14 days). (Each Cycle is 14 days) Maintenance tx: All subsequent Cycles: Treatment with CPI-613 \[2,500 mg/m2/day IV\] over 2 hours (+/- 10 mins) on Days 1-5 (Each Cycle is 21 days)
Memorial Sloan Kettering Cancer Center, New York
Memorial Sloan Kettering Westchester, Harrison
Memorial Sloan Kettering Nassau, Uniondale
Memorial Sloan Kettering Commack, Commack
University of Pennsylvania (Data Collection Only), Philadelphia
Md Anderson Cancer Center, Houston
City of Hope, Duarte
Massachusetts General Hospital, Boston
Memorial Sloan Kettering Basking Ridge, Basking Ridge
Memorial Sloan Kettering Monmouth, Middletown
Memorial Sloan Kettering Bergen, Montvale
City of Hope Medical Center
OTHER
Massachusetts General Hospital
OTHER
M.D. Anderson Cancer Center
OTHER
George Washington University
OTHER
Memorial Sloan Kettering Cancer Center
OTHER